All stock reportsJUBLPHARMA evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-14T23:41:15.776401+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 82796000000.0
- net_income
- 3985000000.0
- operating_cash_flow
- 10129000000.0
- free_cash_flow
- -4362000000.0
- total_assets
- 155227000000.0
- total_liabilities
- 84271000000.0
- total_equity
- 70928000000.0
- cash
- 12676000000.0
- total_debt
- 36147000000.0
- revenue_growth
- 0.14446057087566522
- earnings_growth
- -0.5252561353347629
- net_margin
- 0.04813034446108508
- roe
- 0.05618373561921949
- debt_to_equity
- 0.509629483419806
- cash_conversion
- 2.5417816813048932
- free_cash_flow_margin
- -0.052683704526788736
- trailing_pe
- 37.3666
- forward_pe
- 7.8186
- peg_ratio
- 0.1396
- price_to_book
- 2.1826
- dividend_yield
- 0.0052
Other positional research
Research only
1 opportunity assessments; compare evidence and conditions below.
Trend Continuation Pullback
Research only. Direction: LONG.
Tests continuation after a controlled retracement within an established trend
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Price breach below slow EMA
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Decision provenance and limitations
- Decision ID
- decision-65a1aa50c2a3c0091a4096d8d25485b72a44aec1a5c1fee17e10f404fa0a2b82
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 8eed79e94c5e8f64e74051c6854b5b080703f5ab657c0e5203f751e5cd237744
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: 54b3a65907c61953a1c14f49102e6ab89a91c38716b8dc52fac05c032a010c77
- daily-price: 0cee71e7b0b30571c1cf7446b6d5d50d0f355b8fe29149ab69d50f7bdac04b98
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: VERIFIED.
- The cached closing price on 2026-10-01 was INR 999.30.
- The trailing 5-session price return was -5.73%.
- The trailing 20-session price return was 10.84%.
- The trailing 60-session price return was 3.34%.
- The trailing 250-session price return was -3.45%.
- Average cached traded value over twenty sessions was INR 343,636,031.
- The closing price was -14.66% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-14T23:41:15.776401+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.14446057087566522.
- The cached financial metric net margin is 0.04813034446108508.
- The cached financial metric roe is 0.05618373561921949.
- The cached financial metric debt to equity is 0.509629483419806.
- The cached financial metric cash conversion is 2.5417816813048932.
- The cached financial metric free cash flow margin is -0.052683704526788736.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.